scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1470-2045(06)70798-7 |
P698 | PubMed publication ID | 16887488 |
P2093 | author name string | Thomas Vogt | |
Michael Landthaler | |||
Albrecht Reichle | |||
Christian Hafner | |||
Brigitte Coras | |||
P2860 | cites work | Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma | Q34222670 |
Endogenous angiogenesis inhibitors | Q34371061 | ||
The anti-angiogenic basis of metronomic chemotherapy | Q35788112 | ||
PPARgamma as a therapeutic target for tumor angiogenesis and metastasis | Q36219139 | ||
New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy | Q36264845 | ||
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma | Q45095311 | ||
A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. | Q45158856 | ||
Activation of PPARγ Specifies a Dendritic Cell Subtype Capable of Enhanced Induction of iNKT Cell Expansion | Q63363446 | ||
Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma | Q79134572 | ||
P433 | issue | 8 | |
P921 | main subject | angiogenesis inhibitor | Q574834 |
metastatic prostate carcinoma | Q55779807 | ||
P304 | page(s) | 695-697 | |
P577 | publication date | 2006-08-01 | |
P1433 | published in | Lancet Oncology Commission | Q13747613 |
P1476 | title | Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes | |
P478 | volume | 7 |
Q40640442 | Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia |
Q42550846 | Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia |
Q59805381 | Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis |
Q37817730 | Paraneoplastic syndromes in prostate cancer. |
Q59793687 | Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue |
Q41961938 | Systems biology: a therapeutic target for tumor therapy |
Search more.